BIOC logo

Biocept (BIOC) Free Cash Flow

Annual FCF

-$14.10 M
-$16.21 M-765.53%

December 31, 2022

Summary

Performance

1-Year Change

-765.53%

3-Year Change

+40.73%

5-Year Change

+33.04%

15-Year Change

+33.04%

BIOC Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

56.96%
BIOC annual free cash flow is higher than 56.96% of companies in Healthcare sector

High & Low

All-time High

$2.12 M
BIOC annual free cash flow is currently -765.53% below its historical high of $2.12 million

3-Year Low

-$14.10 M
BIOC annual free cash flow is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
BIOC previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
BIOC next annual earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

Annual CFO

-$13.29 M
BIOC annual cash flow from operations is -$13.29 million

Annual CFF

-$1.87 M
BIOC annual cash flow from financing activities is -$1.87 million

Annual CFI

-$807.00 K
BIOC annual cash flow from investing activities is -$807.00 thousand

Annual CAPEX

$807.00 K
BIOC annual capital expenditures is $807.00 thousand

Quarterly FCF

-$3.18 M
+$3.10 M+49.36%

June 30, 2023

Summary

Performance

3-Month Change

+49.36%

1-Year Change

+25.23%

3-Year Change

+52.55%

5-Year Change

+46.27%

BIOC Quarterly FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

55.83%
BIOC quarterly free cash flow is higher than 55.83% of companies in Healthcare sector

High & Low

All-time High

$1.85 M
BIOC quarterly free cash flow is currently -272.33% below its historical high of $1.85 million

3-Year Low

-$6.29 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

Quarterly CFO

-$3.09 M
BIOC quarterly cash flow from operations is -$3.09 million

Quarterly CFF

$2.97 M
BIOC quarterly cash flow from financing activities is $2.97 million

Quarterly CFI

-$22.00 K
BIOC quarterly cash flow from investing activities is -$22.00 thousand

Quarterly CAPEX

$97.00 K
BIOC quarterly capital expenditures is $97.00 thousand

TTM FCF

-$18.28 M
+$1.07 M+5.55%

June 30, 2023

Summary

Performance

3-Month Change

+5.55%

1-Year Change

-255.03%

3-Year Change

+22.99%

5-Year Change

+23.16%

BIOC TTM FCF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

49.37%
BIOC TTM free cash flow is higher than 49.37% of companies in Healthcare sector

High & Low

All-time High

$2.12 M
BIOC TTM free cash flow is currently -962.94% below its historical high of $2.12 million

3-Year Low

-$19.35 M

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2023
BIOC previous earnings announcement was published on Jun 30, 2023

Next Quarterly Earnings Report Date

N/A
BIOC next earnings announcement has not yet been scheduled

OtherBIOCcash flowmetrics:

TTM CFO

-$17.60 M
BIOC TTM cash flow from operations is -$17.60 million

TTM CFF

$1.91 M
BIOC TTM cash flow from financing activities is $1.91 million

TTM CFI

-$605.00 K
BIOC TTM cash flow from investing activities is -$605.00 thousand

TTM CAPEX

$680.00 K
BIOC TTM capital expenditures is $680.00 thousand

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

Annual FCF

-$14.10 M
BIOC annual free cash flow is -$14.10 million

Annual CFO

-$13.29 M
BIOC annual cash flow from operations is -$13.29 million

Annual CAPEX

$807.00 K
BIOC annual capital expenditures is $807.00 thousand

BIOC Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-765.5%+25.2%-255.0%
3 y3 years+40.7%+52.5%+23.0%
5 y5 years+33.0%+46.3%+23.2%

BIOC Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-765.5%at low-426.8%+49.4%-962.9%+5.5%
5 y5-year-765.5%+40.7%-272.3%+52.8%-962.9%+25.9%
alltimeall time-765.5%+40.7%-272.3%+53.0%-962.9%+25.9%

Biocept Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2023
-
-$3.18 M(-49.4%)
-$18.28 M(-5.6%)
Mar 2023
-
-$6.29 M(+43.6%)
-$19.35 M(+37.3%)
Dec 2022
-$14.10 M(-765.5%)
-$4.38 M(-1.2%)
-$14.10 M(+61.2%)
Sep 2022
-
-$4.43 M(+4.1%)
-$8.74 M(+69.9%)
Jun 2022
-
-$4.26 M(+313.3%)
-$5.15 M(-638.5%)
Mar 2022
-
-$1.03 M(-205.7%)
$956.00 K(-54.9%)
Dec 2021
$2.12 M(-110.3%)
$974.00 K(-216.6%)
$2.12 M(-378.5%)
Sep 2021
-
-$835.00 K(-145.2%)
-$760.60 K(-88.6%)
Jun 2021
-
$1.85 M(+1299.2%)
-$6.67 M(-56.2%)
Mar 2021
-
$132.00 K(-106.9%)
-$15.22 M(-26.3%)
Dec 2020
-$20.65 M(-13.2%)
-$1.90 M(-71.8%)
-$20.65 M(-16.2%)
Sep 2020
-
-$6.74 M(+0.5%)
-$24.66 M(+3.9%)
Jun 2020
-
-$6.71 M(+26.6%)
-$23.73 M(-0.3%)
Mar 2020
-
-$5.30 M(-10.4%)
-$23.80 M(+0.1%)
Dec 2019
-$23.78 M(+5.7%)
-$5.91 M(+1.6%)
-$23.78 M(+2.1%)
Sep 2019
-
-$5.82 M(-14.1%)
-$23.29 M(+1.3%)
Jun 2019
-
-$6.78 M(+28.3%)
-$23.00 M(+3.8%)
Mar 2019
-
-$5.28 M(-2.5%)
-$22.15 M(-1.6%)
Dec 2018
-$22.50 M(+6.9%)
-$5.42 M(-2.0%)
-$22.50 M(-2.9%)
Sep 2018
-
-$5.53 M(-6.7%)
-$23.18 M(+0.2%)
Jun 2018
-
-$5.92 M(+5.2%)
-$23.13 M(+1.4%)
Mar 2018
-
-$5.63 M(-7.7%)
-$22.81 M(+8.4%)
DateAnnualQuarterlyTTM
Dec 2017
-$21.05 M(+30.1%)
-$6.10 M(+11.3%)
-$21.05 M(+8.0%)
Sep 2017
-
-$5.48 M(-2.3%)
-$19.48 M(+14.4%)
Jun 2017
-
-$5.61 M(+45.1%)
-$17.04 M(+6.5%)
Mar 2017
-
-$3.87 M(-14.7%)
-$16.00 M(-1.1%)
Dec 2016
-$16.18 M(+5.6%)
-$4.53 M(+49.5%)
-$16.18 M(+1.4%)
Sep 2016
-
-$3.03 M(-33.7%)
-$15.95 M(-4.4%)
Jun 2016
-
-$4.57 M(+12.9%)
-$16.68 M(+4.2%)
Mar 2016
-
-$4.05 M(-6.0%)
-$16.01 M(+4.5%)
Dec 2015
-$15.32 M(+2.3%)
-$4.30 M(+14.6%)
-$15.32 M(+6.2%)
Sep 2015
-
-$3.76 M(-3.7%)
-$14.43 M(+0.9%)
Jun 2015
-
-$3.90 M(+16.3%)
-$14.29 M(+8.0%)
Mar 2015
-
-$3.35 M(-1.7%)
-$13.23 M(-11.6%)
Dec 2014
-$14.97 M(+141.3%)
-$3.41 M(-5.9%)
-$14.97 M(+16.2%)
Sep 2014
-
-$3.62 M(+27.6%)
-$12.88 M(+16.2%)
Jun 2014
-
-$2.84 M(-44.2%)
-$11.09 M(+16.6%)
Mar 2014
-
-$5.09 M(+284.3%)
-$9.51 M(+53.3%)
Dec 2013
-$6.20 M(-28.0%)
-$1.33 M(-27.6%)
-$6.20 M(+27.2%)
Sep 2013
-
-$1.83 M(+45.1%)
-$4.88 M(+60.1%)
Jun 2013
-
-$1.26 M(-29.3%)
-$3.05 M(+70.7%)
Mar 2013
-
-$1.78 M
-$1.78 M
Dec 2012
-$8.62 M(-23.6%)
-
-
Dec 2011
-$11.28 M
-
-

FAQ

  • What is Biocept annual free cash flow?
  • What is the all time high annual FCF for Biocept?
  • What is Biocept annual FCF year-on-year change?
  • What is Biocept quarterly free cash flow?
  • What is the all time high quarterly FCF for Biocept?
  • What is Biocept quarterly FCF year-on-year change?
  • What is Biocept TTM free cash flow?
  • What is the all time high TTM FCF for Biocept?
  • What is Biocept TTM FCF year-on-year change?

What is Biocept annual free cash flow?

The current annual FCF of BIOC is -$14.10 M

What is the all time high annual FCF for Biocept?

Biocept all-time high annual free cash flow is $2.12 M

What is Biocept annual FCF year-on-year change?

Over the past year, BIOC annual free cash flow has changed by -$16.21 M (-765.53%)

What is Biocept quarterly free cash flow?

The current quarterly FCF of BIOC is -$3.18 M

What is the all time high quarterly FCF for Biocept?

Biocept all-time high quarterly free cash flow is $1.85 M

What is Biocept quarterly FCF year-on-year change?

Over the past year, BIOC quarterly free cash flow has changed by +$1.07 M (+25.23%)

What is Biocept TTM free cash flow?

The current TTM FCF of BIOC is -$18.28 M

What is the all time high TTM FCF for Biocept?

Biocept all-time high TTM free cash flow is $2.12 M

What is Biocept TTM FCF year-on-year change?

Over the past year, BIOC TTM free cash flow has changed by -$13.13 M (-255.03%)